Avience Biomedicals (NSE:AVIENCE) Buyback Yield %: 0.00 (As of Jun. 29, 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Buyback Yield %?

Avience Biomedicals NSE:AVIENCE 5 Buyback Yield % is 0.00 as of Jun. 29, 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100. Among 345 Medical Devices & Instruments companies, Avience Biomedicals ranks worse than 289854.78% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Avience Biomedicals's current buyback yield was 0.00%.


Avience Biomedicals Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Buyback Yield % Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Buyback Yield %
0.00 0.00 0.00

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Buyback Yield % 0.00 0.00 0.00 0.00

NSE:AVIENCE vs ABT, SYK, MDT: Buyback Yield % Comparison

For the Medical Devices subindustry, Avience Biomedicals's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avience Biomedicals Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Avience Biomedicals's Buyback Yield % falls into.


NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Avience Biomedicals's Buyback Yield for the fiscal year that ended in Mar. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 36.046) / 0
=N/A%

Avience Biomedicals's annualized Buyback Yield for the quarter that ended in Jan. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Avience Biomedicals (NSE:AVIENCE) has a Buyback Yield % of 0.00 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Avience Biomedicals and its competitors. According to the industry distribution chart, Avience Biomedicals ranks #999999 out of 345 companies in the Medical Devices & Instruments industry.
Is Avience Biomedicals' Buyback Yield % too high?
Avience Biomedicals' current Buyback Yield % is 0.00. Based on the distribution chart, Avience Biomedicals ranks #999999 out of 345 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #999999 out of 345 companies for Buyback Yield %. This places Avience Biomedicals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Buyback Yield % is 0.00 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price